UCB (UCB)

Index: BEL 20
-0.31%
-€0.19
€65.10
12:30 23/10/17
€65.10
12:30 23/10/17
DAILY VARIATION
-0.31%
-€0.19
VOLUME
237,823
REAL TIME BATS
€61.28
12:33 23/10/17
-0.22%
-€0.14
DATA
52 Week High
€78.25
52 Week Low
€55.74
Shares Issued
188.00m
Market Cap
€12,238.80m
RiskGrade
n/a
Beta
0.97
MENU

UCB Overview

UCB is a Belgian manufacturer of biopharmaceutical products. The company is engaged in the provision of therapy for central nervous system disorders, inflammatory and oncology disorders. UCB head office is located in Brussels.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 1.9% 2.0%
Div Cover 2.5 3.3
Op Mrgn 22.7% 20.9%
ROCE 0.0%
Latest F'cast
P/E 21.3 1,495.4
PEG 0.7 0.3
Pr/Revenue 3.0 2.6
Pr/Book 2.1
Latest F'cast
Revenue 9.9% -0.6%
PBT 79.3% n/a
EPS 32.7% 5.6%
DPS 4.5% -5.1%

Key Fundamentals

slide to see more
Year Ending Revenue (€ m) Pre-tax (€ m) EPS P/E PEG EPS Grth. Div Yield
2012-12-31 3,070.00 263.00 130.00¢ 33.2 10.5 3% 102.00¢ 2.4%
2013-12-31 2,795.00 121.00 124.00¢ 43.7 -9.5 -5% 104.00¢ 1.9%
2014-12-31 2,938.00 111.00 169.00¢ 37.4 1.0 36% 106.00¢ 1.7%
2015-12-31 3,512.00 426.00 217.00¢ 38.4 1.4 28% 110.00¢ 1.3%
2016-12-31 3,858.00 764.00 288.00¢ 21.1 0.6 33% 115.00¢ 1.9%

Forecast

slide to see more
Year Ending Revenue (€ m) Pre-tax (€ m) EPS P/E PEG EPS Grth. Div Yield
2017-12-31 4,388.20 915.91 401.19c 1,495.4 38.0 39% 120.88c 2.0%
2018-12-31 4,550.20 1,049.17 448.07c 1,324.2 113.3 12% 128.75c 2.1%

Regulatory News

No results found

Newspaper Links

No results found